| Name | Title | Contact Details |
|---|
It is the mission of Veterans Legal Services to help Massachusetts veterans overcome adversity by providing free civil legal aid that honors their service, promotes well-being, and responds to their distinctive needs. Veterans Legal Services (VLS) is a 501(c)3 non-profit organization and is the leader in providing free legal advice and representation to homeless and low-income veterans in the Greater Boston area and serves over 500 veterans cases per year at its legal clinics. By locating legal clinics at homeless shelters and service centers, VLS reaches members of our society who are often reluctant to seek legal help and is able to partner with shelter staff to provide holistic support. During its legal clinics, VLS staff attorneys supervise volunteer law students who perform client intakes. After determining eligibility and performing due diligence, VLS offers the veteran either on-the-spot advice, brief service such as helping with pleadings, or full legal representation, up to and including representing the veteran in court or in front of state/federal agencies. VLS is the only legal aid organization in Massachusetts whose mission is to serve veterans. VLS prioritizes veterans where legal representation may yield a life-changing result that restores a veterans self-sufficiency and dignity. We prioritize cases for the disabled, victims of domestic violence, and cases where there is a significant disparity in resources or the opposing party has representation. Veterans Legal Services serves over 500 veterans cases per year at its legal clinics. Previously known as Shelter Legal Services, in late 2013 we began doing business as Veterans Legal Services to better reflect our mission of serving those who serve our country.
Kinney Recruiting is home of some of the most respected legal recruiters in the world, proudly serving markets around the globe. Kinneys Asia practice includes Hong Kong, Tokyo, Beijing, Shanghai, and Singapore, among others. Our U.S. services focus on Arizona, California, Florida, Texas, and New York. Additionally, Kinney Recruiting is active in Dubai, London, Moscow, and the rest of Europe. If you are interested in legal recruiting services for your organization, or if you are a potential candidate for our services, please browse our site until you are comfortable with our philosophy and practices. Kinney Recruiting is committed to serving our clients interests in an ethical and effective manner, ultimately matching the right candidate with the perfect job. Contact us today to start your search!
Alvarez Stauffer Bremer PLLC is a full service law firm, located in downtown Houston, specializing in Pre-Litigation Disputes, Commercial Litigation, Energy Litigation, Mass Tort and Catastrophic Incident Litigation, Arbitration, and eDiscovery. ASB proudly represents international energy companies, large health-care and hospital systems, and pipeline operators — not to mention individuals and closely held companies.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.